Although RSPO2 ovarian localization and RSPO2 promoter studies are needed to assess a putative direct transcriptional activation of RSPO2 by FOXL2, RSPO2 can be considered as a good candidate gene for premature ovarian failure and XX sex-reversal in human. The gene discussed is FOXL2; the disease is primary ovarian failure.